Annual EBIT:
-$266.90M-$31.02M(-13.15%)Summary
- As of today, VRDN annual earnings before interest & taxes is -$266.90 million, with the most recent change of -$31.02 million (-13.15%) on December 31, 2024.
- During the last 3 years, VRDN annual EBIT has fallen by -$187.49 million (-236.11%).
- VRDN annual EBIT is now -135383.76% below its all-time high of -$197.00 thousand, reached on December 31, 2013.
Performance
VRDN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$106.77M-$12.90M(-13.74%)Summary
- As of today, VRDN quarterly earnings before interest & taxes is -$106.77 million, with the most recent change of -$12.90 million (-13.74%) on June 30, 2025.
- Over the past year, VRDN quarterly EBIT has dropped by -$34.58 million (-47.90%).
- VRDN quarterly EBIT is now -2093570.59% below its all-time high of $5100.00, reached on December 31, 2013.
Performance
VRDN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$371.58M-$34.58M(-10.26%)Summary
- As of today, VRDN TTM earnings before interest & taxes is -$371.58 million, with the most recent change of -$34.58 million (-10.26%) on June 30, 2025.
- Over the past year, VRDN TTM EBIT has dropped by -$120.80 million (-48.17%).
- VRDN TTM EBIT is now -268580.40% below its all-time high of -$138.30 thousand, reached on December 31, 2013.
Performance
VRDN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VRDN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -13.2% | -47.9% | -48.2% |
| 3Y3 Years | -236.1% | -261.1% | -276.6% |
| 5Y5 Years | -550.4% | -1601.7% | -1153.1% |
VRDN EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -236.1% | at low | -258.5% | at low | -225.0% | at low |
| 5Y | 5-Year | -550.4% | at low | -1910.7% | at low | -1153.1% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
VRDN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$106.77M(-13.7%) | -$371.58M(-10.3%) |
| Mar 2025 | - | -$93.87M(-7.3%) | -$337.00M(-12.7%) |
| Dec 2024 | -$266.90M(-13.1%) | -$87.47M(-4.8%) | -$299.04M(-5.7%) |
| Sep 2024 | - | -$83.48M(-15.6%) | -$283.04M(-12.9%) |
| Jun 2024 | - | -$72.19M(-29.1%) | -$250.79M(-5.4%) |
| Mar 2024 | - | -$55.90M(+21.8%) | -$237.88M(+6.5%) |
| Dec 2023 | -$235.89M(-82.3%) | -$71.48M(-39.5%) | -$254.45M(-9.7%) |
| Sep 2023 | - | -$51.22M(+13.6%) | -$232.04M(-10.2%) |
| Jun 2023 | - | -$59.27M(+18.2%) | -$210.60M(-16.4%) |
| Mar 2023 | - | -$72.47M(-47.7%) | -$180.89M(-34.7%) |
| Dec 2022 | -$129.39M(-62.9%) | -$49.07M(-64.7%) | -$134.30M(-17.5%) |
| Sep 2022 | - | -$29.79M(-0.7%) | -$114.32M(-15.9%) |
| Jun 2022 | - | -$29.56M(-14.2%) | -$98.67M(-13.3%) |
| Mar 2022 | - | -$25.89M(+11.0%) | -$87.10M(-9.2%) |
| Dec 2021 | -$79.41M(+27.9%) | -$29.08M(-105.8%) | -$79.73M(-11.7%) |
| Sep 2021 | - | -$14.13M(+21.5%) | -$71.38M(-14.1%) |
| Jun 2021 | - | -$18.00M(+2.8%) | -$62.55M(-23.1%) |
| Mar 2021 | - | -$18.52M(+10.7%) | -$50.83M(-26.1%) |
| Dec 2020 | -$110.21M(-168.5%) | -$20.73M(-290.4%) | -$40.31M(-35.9%) |
| Sep 2020 | - | -$5.31M(+15.4%) | -$29.65M(+16.6%) |
| Jun 2020 | - | -$6.27M(+21.6%) | -$35.57M(+7.0%) |
| Mar 2020 | - | -$8.00M(+20.6%) | -$38.24M(+8.9%) |
| Dec 2019 | -$41.04M | -$10.07M(+10.3%) | -$41.98M(+0.9%) |
| Sep 2019 | - | -$11.23M(-25.6%) | -$42.36M(-5.2%) |
| Jun 2019 | - | -$8.94M(+23.8%) | -$40.28M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$11.74M(-12.3%) | -$40.20M(-21.5%) |
| Dec 2018 | -$31.83M(-21.8%) | -$10.45M(-14.2%) | -$33.08M(-14.1%) |
| Sep 2018 | - | -$9.15M(-3.3%) | -$28.98M(-12.7%) |
| Jun 2018 | - | -$8.86M(-91.8%) | -$25.72M(-6.2%) |
| Mar 2018 | - | -$4.62M(+27.3%) | -$24.21M(+8.7%) |
| Dec 2017 | -$26.13M(-107.7%) | -$6.35M(-7.9%) | -$26.53M(-1.7%) |
| Sep 2017 | - | -$5.89M(+19.9%) | -$26.09M(-7.4%) |
| Jun 2017 | - | -$7.35M(-5.9%) | -$24.29M(-25.1%) |
| Mar 2017 | - | -$6.94M(-17.3%) | -$19.42M(-27.6%) |
| Dec 2016 | -$12.58M(-12.4%) | -$5.91M(-44.9%) | -$15.21M(-24.1%) |
| Sep 2016 | - | -$4.08M(-64.3%) | -$12.26M(-8.4%) |
| Jun 2016 | - | -$2.48M(+9.2%) | -$11.30M(+0.1%) |
| Mar 2016 | - | -$2.73M(+7.5%) | -$11.31M(-1.1%) |
| Dec 2015 | -$11.19M(-62.9%) | -$2.96M(+5.5%) | -$11.19M(-5.7%) |
| Sep 2015 | - | -$3.13M(-25.6%) | -$10.59M(-16.4%) |
| Jun 2015 | - | -$2.49M(+4.7%) | -$9.09M(+3.4%) |
| Mar 2015 | - | -$2.61M(-10.9%) | -$9.41M(-38.4%) |
| Dec 2014 | -$6.87M(-3385.8%) | -$2.36M(-44.3%) | -$6.80M(-53.2%) |
| Sep 2014 | - | -$1.63M(+41.9%) | -$4.44M(-50.5%) |
| Jun 2014 | - | -$2.81M(>-9900.0%) | -$2.95M(-2032.8%) |
| Dec 2013 | -$197.00K(+95.1%) | $5100.00(+103.6%) | -$138.30K(+64.7%) |
| Sep 2013 | - | -$143.40K(+42.3%) | -$391.90K(+53.0%) |
| Dec 2012 | -$4.03M | - | - |
| Dec 2012 | - | -$248.50K(+57.5%) | -$833.50K(-42.5%) |
| Sep 2012 | - | -$585.00K | -$585.00K |
FAQ
- What is Viridian Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual EBIT year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Viridian Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM EBIT year-on-year change?
What is Viridian Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of VRDN is -$266.90M
What is the all-time high annual EBIT for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$197.00K
What is Viridian Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, VRDN annual earnings before interest & taxes has changed by -$31.02M (-13.15%)
What is Viridian Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of VRDN is -$106.77M
What is the all-time high quarterly EBIT for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $5100.00
What is Viridian Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, VRDN quarterly earnings before interest & taxes has changed by -$34.58M (-47.90%)
What is Viridian Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of VRDN is -$371.58M
What is the all-time high TTM EBIT for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$138.30K
What is Viridian Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, VRDN TTM earnings before interest & taxes has changed by -$120.80M (-48.17%)